NSC |
Compound |
Enrichment |
Correlation |
NSC 658798 |
Null |
0.00888636978630782 |
0.45648754 |
NSC 668814 |
1-Oxa-4,7,10,13,16-pentaazacyclononadecane, cyclic peptide derivative |
0.00888636978630782 |
-0.10439216 |
NSC 677697 |
7H-Pyrrolo[2,3-d]pyrimidine, 5,6-dimethyl- 2,4-bis(methylsulfinyl)-7-phenyl- |
0.00888636978630788 |
0.37805466 |
NSC 744025 |
diethyl 2-[4-(5-[(11aS)-7-methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl]oxypentyl)piperazino]ethylphosphonate |
0.00888636978630788 |
0.42786104 |
NSC 759216 |
(3-(4-bromophenyl)-5-(1,3-diphenyl-1H-pyrazol-4-yl)-4,5-dihydropyrazol-1-yl)(4-methoxyphenyl)methanone |
0.00888636978630788 |
0.014793698 |
NSC 721041 |
Null |
0.00940302282078408 |
0.28969511 |
NSC 750717 |
5-(2-hydroxyethyl)-9-(3-methoxyphenyl)-6,9-dihydro-[1,3]dioxolo[4,5-g]furo[3,4-b]quinolin-8(5H)-one |
0.00940302282078408 |
0.51574134 |
NSC 175633 |
4(1H)-Quinazolinone, 2-(2-chlorophenyl)-2,3-dihydro- |
0.0115521552688257 |
0.71373964 |
NSC 3060 |
Arsenenous acid, potassium salt (9CI) |
0.0115521552688257 |
0.31135855 |
NSC 382002 |
Null |
0.0115521552688257 |
0.35528493 |